PTSD

Latest News

FDA Advisory Committee Casts Nearly Unanimous Vote Against Otsuka's PTSD Combination
July 21st 2025
FDA Advisory Committee Casts Nearly Unanimous Vote Against Otsuka's PTSD Combination

The FDA advisory committee overwhelmingly voted against Otsuka's PTSD treatment, citing insufficient evidence from clinical trials for approval.

July 17th 2025

Otsuka and Lundbeck Will Face Scrutiny Over Investigational PTSD Therapy at July 18 FDA AdComm Meeting

Investigational Rapid-Acting PTSD Medication Awarded FDA Breakthrough Therapy Status / image credit ©Feng Yu/stock.adobe.com
July 10th 2025

Investigational Rapid-Acting PTSD Medication Awarded FDA Breakthrough Therapy Status: Transcend Therapeutics Update

February 3rd 2025

Optimizing PTSD Treatment: The Role of Brexpiprazole and Sertraline in Future Guidelines

©MJH Life Sciences
January 29th 2025

PTSD Treatment Advancements: Brexpiprazole-Sertraline Offers New Hope in Phase 3 Trial